Is the decreasing responsiveness of axial motor symptoms to L-dopa in elderly parkinsonian patients related to age-associated nonparkinsonian pathologies?
Ransmayr
G
G
University Clinic of Neurology, Innsbruck, Austria.
Künig
G
G
Neubauer
M
M
Wagner
M
M
Bösch
S
S
Kreczy-Kleedorfer
B
B
D000367:Age Factors; D000368:Aged; D001921:Brain / Q000187:drug effects / Q000503:physiopathology; D003704:Dementia / Q000188:drug therapy / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D009043:Motor Activity / Q000187:drug effects* / Q000502:physiology; D009048:Motor Skills / Q000187:drug effects / Q000502:physiology; D009069:Movement Disorders / Q000188:drug therapy / Q000503:physiopathology; D009127:Muscle Rigidity / Q000188:drug therapy / Q000503:physiopathology; D009460:Neurologic Examination / Q000187:drug effects*; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology
D007980:Levodopa